• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD INC. (COVINGTON) -1018233 SURESTEP INTERMITTENT CATHETER TRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD INC. (COVINGTON) -1018233 SURESTEP INTERMITTENT CATHETER TRAY Back to Search Results
Catalog Number INTL15
Medical Device Problem Code Restricted Flow rate (1248)
Health Effect - Clinical Codes Discomfort (2330); No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/13/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that the new straight catheter leg bag to drain was collapsed on itself, so it did not drain.Customer had a patient that it took 45 minutes for the urine to fully drain.Nurses have said the bags were so compressed they did not allow urine to flow into the bag.Correct bag would not open and allow urine to drain, it took 45 mins to drain 700ml.Nurse did not utilize another kit.Did cause patient discomfort.No medical intervention was reported.
 
Additional Manufacturer Narrative
The reported event was inconclusive because no sample was available for evaluation and further investigation did not result in any additional findings.No actions can be taken at this time since a root cause was not identified.A review of the device history record did not show any problems or conditions that would have contributed to the reported issue.The instructions for use were found adequate and state the following: indications for use: pvc & red rubber: for urological use only.Silicone: intended for use for bladder.Management including urine drainage, collection and measurement.The devices are generally passed to the urinary bladder via the urethra.Bard ez-lok sampling port (indicated by the blue stem in the port) accepts luer lock (fig.1a) or slip tip collection devices (fig.1b).Bd vacutainer urine products can be used for collection, storage, and transport of urine specimens from a urinary catheter.1.Swab surface of bard ez-lok sampling port with antiseptic (fig.2) e.G., site-scrub ipa device which is an effective disinfecting agent for luer hubs.2.Using aseptic technique, position the collection device in the center of the sampling port.Press the device firmly and twist gently to access the sampling port.(fig.3).3.If using bd vacutainer luer-lok access device (fig.4), collect urine into the bd vacutainer tubes per hospital protocol.If using syringe, slowly aspirate urine sample into syringe and transfer to collection cup or follow hospital protocol.4.After sample is obtained, discard collection device according to hospital protocol.5.Follow established hospital protocol for specimen labeling and transport to lab.Single use only.Do not resterilize.For urological use only.Warning: on catheter, do not use ointments or lubricants having a petrolatum base.They will damage the catheter.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
It was reported that the new straight catheter leg bag to drain was collapsed on itself, so it did not drain.Customer had a patient that it took 45 minutes for the urine to fully drain.Nurses have said the bags were so compressed they did not allow urine to flow into the bag.Correct bag would not open and allow urine to drain, it took 45 mins to drain 700ml.Nurse did not utilize another kit.Did cause patient discomfort.No medical intervention was reported.Per follow up response received via email on 04dec2024, this was a complaint from this summer.Since then, they had catheter bard education.They would say that nursing staff have still found this a challenge, but a few education techniques have helped.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURESTEP INTERMITTENT CATHETER TRAY
Common Device Name
INTERMITTENT CATHETER TRAY
Manufacturer (Section D)
C.R. BARD INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer (Section G)
C.R. BARD INC. (COVINGTON) -1018233
8195 industrial blvd
covington GA 30014
Manufacturer Contact
xeeroy rada
8195 industrial blvd
covington 30014
7707846100
MDR Report Key20371454
Report Number1018233-2024-06245
Device Sequence Number12458239
Product Code KOD
UDI-Device Identifier00801741183171
UDI-Public(01)00801741183171(11)240307(17)250731(10)NGJP0945
Combination Product (Y/N)Y
Initial Reporter StateIA
Initial Reporter CountryUS
PMA/510(K) Number
EXEMPT
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Other,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/07/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/31/2025
Device Catalogue NumberINTL15
Device Lot NumberNGJP0945
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/13/2024
Supplement Date Received by Manufacturer01/07/2025
Initial Report FDA Received Date10/04/2024
Supplement Report FDA Received Date01/09/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/07/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-